RNAi has revolutionized loss-of-function genetics by enabling sequence-specific suppression of virtually any gene. Furthermore, tetracycline response elements (TRE) can drive expression of short hairpin RNAs (shRNAs) for inducible and reversible target gene suppression. Here, we demonstrate the feasibility of transgenic inducible RNAi for suppression of essential genes. We set out to directly target cell proliferation by screening an RNAi library against DNA replication factors and identified multiple shRNAs against Replication Protein A, subunit 3 (RPA3). We generated transgenic mice with TRE-driven Rpa3 shRNAs whose expression enforced a reversible cell cycle arrest. In adult mice, the block in cell proliferation caused rapid atrophy of the intestinal epithelium which led to weight loss and lethality within 8-11 d of shRNA induction. Upon shRNA withdrawal, villus atrophy and weight loss were fully reversible. Thus, shRpa3 transgenic mice provide an interesting tool to study tissue maintenance and regeneration. Overall, we have established a robust system that serves the purpose of temperature-sensitive alleles in other model organisms, enabling inducible and reversible suppression of essential genes in a mammalian system.
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RNAi transgenics | gene targeting | mouse genetics | conditional knockout | mouse models L oss-of-function experiments reveal the biological function of a gene of interest through the phenotype that results from its deficiency. The most dramatic phenotype is lethality, defining a gene as essential. Although such a striking phenotype places essential genes among the most interesting, it also renders them the most difficult class of genes to study. First, null alleles must be maintained as a heterozygous stock. Second, in homozygotes, the role of the gene can be studied only in the developmental stages preceding lethality. Thus, any function the gene might play later in development remains unknown. Additionally, the absence of a gene throughout development may induce compensatory shifts in related pathways, confounding the interpretation of results (1) .
In simple model organisms, temperature-sensitive mutants isolated in forward genetic screens are crucial to studying essential genes. These lines can be maintained at permissive temperature, and simply shifting to restrictive temperature reveals the mutant phenotype. Thus, essential genes can be acutely and transiently inactivated at any stage in development.
Although such tools are not available in mouse models, conditional deletion alleles in which the gene of interest is flanked by loxP recombination sites enable acute gene inactivation upon expression of Cre recombinase. Expression of Cre from tissuespecific promoters yields gene deletion in a restricted compartment, whereas the use of tamoxifen-inducible Cre alleles allows precise timing of recombination. However, these approaches require costly and time-consuming generation of customized targeting cassettes and production of ES cells by homologous recombination. Also, Cre-mediated gene excision is incomplete, and the efficiency of excision varies with respect to the size of the targeted cassette (2) . Furthermore, continuous expression of Cre can have genotoxic and/or mutagenic side effects, potentially confounding the interpretation of results, especially when studying DNA damage or metabolism (3) (4) (5) . Most importantly, conditional gene deletion is not reversible, so these models cannot be used to determine the effect of transient gene inactivation, during windows of development or in the adult.
In recent years, RNAi has enabled fast and versatile loss-offunction studies in mammalian cells through transient transfection of synthetic small interfering RNAs or transduction of viral vectors that drive stable or inducible expression of shRNAs. In a transgenic setting, shRNA expression alleles recapitulate knockout mouse phenotypes when constitutively or inducibly expressed, thus providing an alternative to Cre-mediated gene deletion (6) (7) (8) (9) (10) (11) (12) (13) (14) . Importantly, shRNAs under the control of the reversible tetracycline-responsive element (TRE) allow both inducible gene knockdown and rapid reactivation (15, 16) . Moreover, shRNA transgenesis is faster than generation of conventional and conditional knockouts because it obviates the need for site-specific homologous recombination, and, because RNAi suppresses gene function in trans, only a single transgenic allele is necessary, thus reducing animal husbandry. Therefore, we envisaged inducible RNAi transgenics as an effective tool to dissect the role of essential genes in mice.
We recently developed a rapid, scalable platform for the generation of inducible shRNA transgenic mice and used it to study suppression and reactivation of tumor suppressor genes, whose inactivation promotes cancer development (17) . Here, we address the challenge of targeting essential genes, a unique setting where expression of the shRNA could be deleterious, enforcing selective pressure against induction of the transgene. To determine whether this system would be sufficiently robust to induce lethal phenotypes and thus accurately assess essential gene function, we chose to inhibit an essential process by RNAi: DNA synthesis. Our results show that transgenic RNAi targeting the DNA replication machinery causes widespread inhibition of cell proliferation in adult mice, and thus dramatic phenotypes arise in highly proliferative tissues. More generally, our results establish a robust and versatile platform to study virtually any essential gene in mice.
Results
shRNAs Targeting RPA Strongly Inhibit Cell Proliferation. An shRNA screen was conducted in HCT116 colorectal carcinoma cells to identify genes involved in DNA synthesis that were sensitive to RNAi inhibition. A library of 254 shRNAs targeting genes with either established or suspected roles in DNA replication was cloned into a retroviral construct in the context of a human miR-30 transcript. For each shRNA, cells were transduced, selected with puromycin, and counted 5 d following transduction. Many shRNAs were identified that reduced cell number more than twofold compared with controls, including multiple shRNAs targeting PES1 and the RPA complex ( Fig. 1 A-C) . PES1 encodes a protein implicated in cell cycle progression and ribosome biogenesis (18, 19) . RPA is the heterotrimeric singlestranded DNA binding complex that stabilizes replication forks by coating melted DNA; the RPA complex also binds ssDNA at sites of DNA damage and recruits cell cycle checkpoint kinases (reviewed in refs. 20 and 21). Two anti-proliferative shRNAs targeting the smallest RPA subunit, RPA3, induce degradation of all three members of the RPA complex, whereas RPA1 shRNA knocks down only its target (Fig. S1A) . We chose to use RPA3 shRNAs in further studies because of its well characterized roles in DNA replication and repair and because its sole suppression destabilized the entire RPA complex. To study Rpa3 knockdown in transgenic mice, shRNAs were cloned that potently targeted mouse Rpa3 (Fig. S1B) .
TREtight Prevents Sterility in shRpa3 Founder Mice. To facilitate the fast and reproducible generation of shRNA transgenic mice, we used a recently developed targeting cassette that enables efficient integration of an inducible shRNA transgene at a defined genomic locus (17, 22) . This targeting vector consists of a miR-30-based shRNA embedded in the 3′ UTR of a GFP transcript downstream of the inducible TRE-CMV promoter (TRE; Fig.  S1C ). In this configuration, fluorescence reports the level of induction of the shRNA transcript.
Following electroporation of the targeting vector and a plasmid expressing Flpe recombinase into KH2 ES cells (22) , recombinase-mediated cassette exchange promotes integration of the TRE-GFP-miR/shRNA (TGM) cassette into a defined locus downstream of the collagen A1 gene (ColA1; ref. 17) . In addition to the ColA1 homing cassette, KH2 cells are also transgenic at the Rosa26 locus where a modified reverse tetracycline transactivator coding sequence (rtTA-M2) is knocked in downstream of the endogenous Rosa26 promoter (22, 23) . rtTA drives strong reversible expression from the TRE promoter in the presence of the tetracycline analog doxycycline (dox) (24) , allowing immediate testing of TRE function in targeted ES cells.
Using this system, one weak (shRpa3.429) and one potent (shRpa3.455) shRNA against mouse Rpa3 were targeted to the ColA1 locus. As expected, dox treatment of each targeted clone induced strong GFP expression and knockdown of Rpa3, effects that were reversed when dox was withdrawn (Fig. S1B) . Next, fully transgenic mice were generated by injecting these ES cells into tetraploid blastocysts. The resulting animals developed normally, but only transgenics harboring the weak TG-shRpa3.429 were fertile. Although the ES cells showed no GFP expression or Rpa3 knockdown in the absence of dox (Fig. S1B) , we hypothesized that the sterility in strong TG-shRpa3.455 founders was caused by low levels of the shRpa3 inhibiting meiotic recombination during germline development, because Rpa is required for recombination. Furthermore, ES cells harboring inducible shRNAs targeting many nonessential genes yielded viable founder lines (17) .
To circumvent this issue, the shRNA targeting construct was modified to contain a TREtight promoter (Tt), which shows 40-fold lower expression in the absence of dox than the conventional TRE promoter (25) . The GFP spacer was also changed to a fastmaturing fluorescent protein (turboRFP; herein cited as tRFP) for rapid fluorescent detection of induction, to yield the final Tt-tRFP-miR/shRNA (TtRM) cassette. Additionally, a second strong Rpa3 shRNA was identified through a high-throughput assay of shRNA potency described elsewhere (26) , and thus KH2 ES cells were targeted with two different potent Rpa3 shRNAs (shRpa3.455 and shRpa3.561) or a potent shRNA against firefly luciferase (shLuci) in TtRM. Again, tRFP was strongly induced by dox and reported concomitant Rpa3 knockdown in shRpa3-targeted ES cells, and both tRFP level and knockdown were quickly reversed upon dox withdrawal ( Fig. 2A Left) . These cells were used for tetraploid blastocyst complementation and yielded fertile founder lines, suggesting that TREtight prevented deleterious leaky expression of shRpa3.
Transgenic Rosa26-rtTA;TtR-shRpa3 MEFs Reversibly Arrest in Dox. As a first step in characterizing the functional consequences of Rpa3 inhibition in transgenic cells, mouse embryonic fibroblasts (MEFs) were isolated from embryos transgenic for both Rosa26-rtTA-M2 (Rosa-rtTA) and TtRM (23, 25) and examined for Rpa3 expression and proliferation in the absence or presence of dox. A 4-d pulse of dox treatment resulted in rapid, reversible induction of tRFP in all cells, along with Rpa3 knockdown in shRpa3 MEFs, but not shLuci MEFs ( Fig. 2A Right) . Accordingly, Rosa-rtTA; shRpa3 MEFs arrested after 4 d in dox (Fig. 2B) , whereas those grown in the absence of dox continued to multiply similar to shLuci controls. Dox treatment did not result in a significant increase in apoptotic cells (Fig. S2 ). This defect in proliferation was completely reversible, as arrested cells resumed proliferation within days of dox withdrawal, eventually proliferating as rapidly as untreated controls (Fig. 2C) .
To further characterize the nature of the shRpa3-induced cell cycle arrest, MEFs were BrdU-pulsed and analyzed by flow cytometry after 0, 2, 4, or 6 d of dox treatment. Cell cycle analysis of Rosa-rtTA;shRpa3 MEFs showed an accumulation of BrdUnegative cells with greater than 2C DNA content upon dox treatment, indicative of arrest in S phase (Fig. 2 D and E) . In these cells, dox treatment induced phosphorylation of Chk2, but did not lead to a strong induction of gamma-H2A.X, indicating that the cell cycle arrest caused by Rpa3 knockdown is not the result of a DNA damage-induced cell cycle checkpoint caused by stalled replication (Fig. 2F) .
To determine whether shRNA-mediated Rpa3 suppression was sufficient to interfere with checkpoint signaling, Rosa-rtTA; shRpa3 MEFs were treated with hydroyurea (HU) or ionizing radiation (IR). In the absence of dox, both HU and IR strongly induced phosphorylation of Chk1, Chk2, and H2A.X (Fig. 2F) . In cells treated with dox for 4 d before HU or IR, Chk1 phosphorylation was abrogated, whereas Chk2 and H2A.X phosphorylation were unaffected. These data demonstrate that Rpa3 knockdown can impede Chk1 signaling, consistent with previous work showing that the Rpa complex is required for recruitment and activation of ATR kinase at sites of DNA damage (27, 28) . Thus, inducible knockdown of Rpa in vitro recapitulates known loss of function phenotypes, demonstrating that our system is suitable for further characterization of this and other essential genes.
Adult CMV-rtTA;Rosa-rtTA;shRpa3 and Rosa-rtTA +/+ ;shRpa3 Mice Exhibit Rapid Weight Loss Upon Dox Treatment. A key advantage of inducible shRNA transgenics targeting essential genes is to bypass embryonic lethality and examine the impact of inducible gene knockdown at later stages of development or in the adult. Consistent with the ongoing need for cell proliferation during embryogenesis, bitransgenic Rosa-rtTA;TtR-shRpa3 animals died shortly after birth when treated with dox in utero. Surprisingly, if Rosa-rtTA;TtR-shRpa3 mice were treated with dox at adulthood (6 wk of age), no overt phenotype was observed. Notably, fluorescent reporter expression was much lower in adults than in embryos and substantially more tissue-restricted, suggesting that this discrepancy might arise from insufficient shRNA expression rather than a reduced requirement for Rpa3 in the adult. When shRpa3 mice were crossed to the CMV-rtTA strain (24) and treated with dox at 6 wk of age, fluorescence was observed in more widespread tissues but still no obvious phenotype resulted. However, when mice were triple transgenic CMV-rtTA;Rosa-rtTA;shRpa3 or RosartTA;Rosa-rtTA;shRpa3 (Rosa-rtTA +/+ ;shRpa3), shRNA induction by dox treatment led to cell cycle arrest and caused rapid weight loss, even in the case of weak shRpa3.429 (Fig. 3) .
Although shRpa3-induced weight loss led to death in most cases, some mice regained weight and survived while continuously treated with dox ( Fig. S3 A and B) . Only mice with strong Rpa3 shRNAs that were homozygous for Rosa-rtTA (RosartTA +/+ ;TtR-shRpa3) never survived dox treatment at 6 wk of age (Fig. S3A) . We hypothesized that less penetrant phenotypes could be due to weak or mosaic shRNA expression, which would lead to the outgrowth of cells that did not efficiently induce the shRNA (see also ref. (Fig. S4A) . Furthermore, multiple tissues of Rosa-rtTA;TtR-shRpa3 and CMV-rtTA;Rosa-rtTA; TtR-shRpa3 mice that survived long-term dox treatment were less tRFP-positive than those in treated shLuci counterparts (Fig. S4 B and C), suggesting that selection occurs against shRpa3 expression but not against neutral shLuci. Therefore, the expression pattern of the tet-transactivator, and in turn, the TRE-driven shRNA, influences the extent of phenotype in this system. ;TtR-shLuci mice continued to gain weight at a rate typical of 6-wk-old animals. Dramatic total weight loss was accompanied by moderate decrease in size and weight of individual organs such as the liver, kidneys, and spleen (Fig. S5A) .
To determine which systems were most likely affected by shRNA expression in Rosa-rtTA +/+ ;TtR mice, we assessed tRFP fluorescence throughout the body. Based on tRFP levels, RosartTA +/+ drove TRE expression in many tissues including skin, bone marrow, spleen and pancreas, but levels were highest in the intestine. Accordingly, histology revealed the rapid degeneration of the intestinal epithelium in Rosa-rtTA +/+ ;TtR-shRpa3 mice over the time course of dox treatment (Fig. 4C) . Immunohistochemistry for tRFP shows strong expression of the tRFP-shRNA cassette by day 3 on dox ( Fig. 4C) . Rpa3 knockdown in the intestine is observed by 5 d on dox, as was a reduction in proliferating cells and BrdU incorporation (Fig. 4 B-D and Fig. S6 A  and B) . By day 7, intestinal architecture is severely disrupted, and Ki67-positive cells are reduced by fourfold (Fig. 4 C and D) . Rpa3 shRNA did not cause a significant increase in apoptotic cells in the intestine (Fig. S6C) . Importantly, this effect was not due to overexpression of an exogenous miR, as the expression of a luciferase shRNA had no effect on intestinal proliferation or architecture (Fig. 4 C and D and Fig. S6 A and B) . Two independent Rpa3 shRNAs show the same effect, ruling out off- In the bone marrow of Rosa-rtTA +/+ ;TtR-shRpa3 mice, erythroid precursors are severely depleted after 3 d on dox food compared with shLuci controls (Fig. 4E ). This effect is transient and does not lead to a significant anemia in the periphery. Also, no significant change in overall BrdU incorporation was observed in the bone marrow. We hypothesized that the transience of this phenotype might be due to compensation by cells that fail to express the shRNA cassette. In the bone marrow of control shLuci mice, 35-67% cells were tRFP-positive. Consistent with a rapid selection against shRpa3 expression, tRFP-positive cells were relatively depleted in the bone marrow of shRpa3 mice treated with dox (8-26%, Fig. 4F) . Thus, the fluorescent reporter can be used as a read-out of cell-autonomous effects of knockdown in tissues where expression of the tRFP-shRNA transcript is mosaic. Reversible. Because shRpa3-induced cell cycle arrest was reversible in vitro, we aimed to determine whether the effects of shRpa3 expression were reversible in vivo, and if dox withdrawal could rescue weight loss and tissue defects in this model. Therefore, 6-wk-old Rosa-rtTA +/+ ;TtR-shRpa3 mice were treated with a 3-d pulse of dox food and then returned to a dox-free diet. These mice exhibited a delay in weight gain relative to shLuci controls and mild weight loss but eventually regained weight at a rate similar to controls (Fig. 5A) . In CMV-rtTA;Rosa-rtTA;TGshRpa3.429 mice, which could be left on dox longer (10 d), a more marked weight loss and subsequent regain was observed upon dox withdrawal (Fig. S7) .
Again, we extended our characterization of this recovery in the most penetrant Rosa-rtTA +/+ ;TtR-shRpa3 model. Here, 5 d after beginning dox treatment (2 d after dox withdrawal), the intestinal epithelium showed moderate atrophy and loss of proliferating cells similar to that in mice treated with dox continually for 5 d (Figs. 4C and 5C ). By 7 d after dox withdrawal, tRFP expression was diminished (Fig. 5C ), demonstrating extinguished TRE-tight expression. At this time point, mice had recovered a normal number of proliferating cells in the intestine and normal tissue architecture, and liver, kidney, and spleen weights were comparable to controls (Fig. 5 B and C and Fig. S5B) . Thus, the effects of Rpa3 knockdown were fully reversible upon shRpa3 withdrawal. Hence, our system shows that transient inactivation of the replication gene Rpa3 causes a reversible inhibition of DNA synthesis but is not invariably lethal, thus providing a system to study this essential process at different developmental stages and, through the use of tissue specific tranactivators, in particular cell types. More broadly, our study provides a platform and blueprint to suppress and reactivate any essential gene in vivo.
Discussion
Here, we establish that an inducible RNAi transgenic system is useful to study genes that are essential in adult tissues. By targeting cell proliferation, we showed that this system is sufficiently robust to examine deleterious phenotypes induced by knockdown. Importantly, we used a fluorescent protein encoded on the same transcript as the shRNA to tightly report the level of shRNA induction at single cell resolution. This feature highlights which tissues are most likely to exhibit a phenotype caused by knockdown and aids in the interpretation of negative results by providing a simple test of whether the shRNA was expressed. In future studies, the reporter could even be used to study cellautonomous effects of knockdown by examining only the fluorescent cells in tissues where shRNA expression is variegated.
Still, many applications of inducible shRNA transgenics require knockdown throughout the tissue of interest. Here, we observed that CMV-rtTA;Rosa-rtTA;shRpa3 mice sometimes regained weight and survived following an initial weight loss, suggesting that a small number of cells that fail to induce or actively silence rtTA or TRE expression can compensate for arrested cells in which shRNA expression is maintained. Accordingly, analysis of the intestines of surviving mice for the shRNA-linked fluorescence reporter indicated that they consisted largely of nonfluorescent cells. Hence, moving forward, more transactivator strains that drive high levels of truly ubiquitous expression from the TRE must be developed. Our group has already generated a superior strain to Rosa-rtTA for driving shRNA expression in widespread adult tissues (17) ; one allele of this transgene, which drives expression of an optimized rtTA (rtTA3) from the CMV early enhancer/chicken β actin (CAG) promoter is sufficient to induce weight loss and death in combination with either a strong or weak shRpa3.
Rpa3 knockdown in CMV-rtTA;Rosa-rtTA;shRpa3 mice disrupted the intestine more than any other tissue; this is likely due to both (i) strong and penetrant expression of the shRNA cassette and (ii) the high rate of cell turnover in this tissue. Because shRNA led to lethality in only 8 d in this model, other tissues might also be dramatically affected by shRNA expression over a longer time scale. The construction of our system allows shRNA transgenic mice to be crossed to tissue-specific transactivators to examine the effect of inducible knockdown in restricted compartments. Again, although numerous tissue-specific transactivator strains exist, many drive mosaic TRE expression within the tissue of interest, so a fluorescent reporter is also indispensable in these backgrounds. As improved ubiquitous and tissue-specific transactivators are developed, dox delivery and TRE accessibility may also be limiting to shRNA expression in some tissues.
The strong antiproliferative effect of shRPA3 was evident in a library of shRNAs targeting DNA replication and cell cycle regulated genes in the cancer cell line HCT116. This may be because RPA is required for DNA replication, DNA repair, and cell cycle checkpoint processes (21) . Consistent with this finding, ribonucleotide reductase (RRM1) is also involved in all three processes and was also identified in the screen. Thus, directly targeting the many roles of RPA is a powerful genetic means to cause reversible cell cycle arrest that does not lead to apoptosis. In transgenics, this provides an interesting tool to study normal tissue maintenance at any stage of development and, with a transient pulse of knockdown, the process of tissue regeneration. For these applications, shRpa3 mice are an interesting complement to existing cell lineage ablation technologies, such as diphtheria toxin or toxin receptor expression (30) (31) (32) . Targeting other essential genes will require careful assessment of shRNA potency because shRNAs against subunits of the Origin Recognition Complex required > 90% knockdown of protein levels to prevent proliferation of HCT116 cells.
More broadly, transient inactivation of essential genes in the whole organism is an exciting prospect for mouse genetics. On a practical level, our platform can be modified through simple cloning to target any gene, leading to transgenic mice within ∼4 mo, up to three times faster than standard gene targeting approaches. More importantly, the ability to toggle gene expression at any developmental stage and examine the outcome later in development is a major advance over conditional gene deletion, which is not reversible. A systemic pulse of gene knockdown is also the closest genetic approximation to a single treatment with a targeted small molecule-based therapy that incompletely inhibits gene function. Thus, this system will be invaluable for testing the efficacy and side effects of inhibiting novel therapeutic targets. In general, this level of genetic malleability brings mouse genetics forward to meet that of other model organisms, which have long used temperature-sensitive mutations to this end. Adding a new layer of versatility, the sequence-specific nature of RNAi allows the rational targeting of any gene of interest inducibly and reversibly. 
